Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic protocol comparison for aspiration pneumonia in opioid-overdosed adults
IRCT20090808002306N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ampicillin, sulbactam, ceftriaxone and clindamycin in aspiration pneumonia (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mortality, Relative improvement and 1 more. Started Nov 2019; status: completed.
02
Drugs
ampicillinsulbactamceftriaxoneclindamycin
03
Conditions
aspiration pneumonia
Beyond the preview
Go deeper on IRCT20090808002306N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090808002306N5.